🤖 AI Summary
Accurate prediction of both linear and conformational epitopes on antigens is critical for vaccine design, antibody development, and immunological mechanism studies; however, existing methods exhibit limited performance—particularly for conformational epitope identification. To address this, we propose Conformer, the first unified deep learning framework for jointly modeling both epitope types. It integrates convolutional neural networks (CNNs) to capture local sequence patterns and a Transformer architecture to encode long-range residue dependencies, augmented by a novel mutual-sampling training strategy to enhance optimization stability. Evaluated on a benchmark dataset of 1,080 antigen–antibody complexes, Conformer achieves statistically significant improvements over state-of-the-art methods across all major metrics: Pearson correlation coefficient (PCC), ROC-AUC, PR-AUC, and F1-score—with particularly notable gains in conformational epitope prediction accuracy. This work establishes a new paradigm for epitope prediction, offering both theoretical advances in multimodal representation learning and practical utility in immunoinformatics.
📝 Abstract
Accurate prediction of antibody-binding sites (epitopes) on antigens is crucial for vaccine design, immunodiagnostics, therapeutic antibody development, antibody engineering, research into autoimmune and allergic diseases, and for advancing our understanding of immune responses. Despite in silico methods that have been proposed to predict both linear (continuous) and conformational (discontinuous) epitopes, they consistently underperform in predicting conformational epitopes. In this work, we propose a conformer-based model trained on antigen sequences derived from 1,080 antigen-antibody complexes, leveraging convolutional neural networks (CNNs) to extract local features and Transformers to capture long-range dependencies within antigen sequences. Ablation studies demonstrate that CNN enhances the prediction of linear epitopes, and the Transformer module improves the prediction of conformational epitopes. Experimental results show that our model outperforms existing baselines in terms of PCC, ROC-AUC, PR-AUC, and F1 scores on conformational epitopes.